Astec LifeSciences Reports Unaudited Financial Results for Quarter Ended June 30, 2026
Astec Lifesciences Ltd announced that its Board of Directors had approved the unaudited financial results (Standalone and Consolidated) for the quarter ended June 30, 2026. The Company also noted the Limited Review Reports of the Statutory Auditors regarding these results.The review reports confirmed that nothing came to the auditors' attention to suggest that the accompanying Statement, prepared in accordance with Indian Accounting Standard (Ind AS), contained any material misstatement.
Financial Performance Overview
The unaudited financial results for the quarter ending June 30, 2026, reflect a net loss after tax at the consolidated level of Rs 1,870.73 lakhs.Key Consolidated figures as per the statement are presented below (amounts in lakhs):
| Particulars | Quarter Ended June 30, 2026 (Unaudited) |
|---|---|
| Revenue From Operations | 8,356.43 |
| Other Income | 72.74 |
| Total Income | 8,429.17 |
| Cost of materials consumed | 7,632.28 |
| Changes in inventories of finished goods and Work-in progress | (3,370.38) |
| Employee benefits expense | 1,599.96 |
| Finance costs | 773.18 |
| Depreciation and amortisation expenses | 1,106.77 |
| Other expenses | 2,561.18 |
| Total Expenses | 10,302.99 |
| Loss Before Tax | (1,873.82) |
| Net Profit/(Loss) after tax | (1,870.73) |
Financial Ratios and Metrics
The company's financial health metrics for the quarter ended June 30, 2026, include several important ratios:| Metric | Consolidated Qtr Ended Jun 30, 2026 |
|---|---|
| Current Ratio | 0.83 |
| Net Worth (in Rs. Lakh) | 37,235.59 |
| Net profit/(loss) after tax (in Rs. Lakh) | (1,870.73) |
| Basic Earnings per share | (8.40) |
| Debt Equity ratio | 0.98 |
| Operating margin (%) | -0.80% |
| Net profit/(loss) margin (%) | -4.88% |
Credit Ratings and Operational Details
The company's credit facilities were assessed by leading credit agencies. ICRA assigned the rating [ICRA] Al+ for its short term facilities (including commercial paper) and [ICRA] AA- for its long term facilities. India Ratings & Research assigned [IND] AA- for its Non Convertible Debentures (NCDs).The consolidated results include entities such as Astec LifeSciences Limited (Holding Company), Behram Chemicals Private Limited, and Comercializadora Agricola Agroastrachem Cia Ltda.
ASTEC Stock Price Movement
Today, Astec LifeSciences Limited shares edged higher to close at ₹646.30 in post-market trading, gaining 3.08% off its previous close. The stock saw significant activity, with a total traded volume of 68,242 shares recorded today.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.